UPSD vs. TMED

Last updated Jul 30, 2026

UPSD (Aptus Large Cap Upside ETF) and TMED (T. Rowe Price Health Care ETF) are both exchange-traded funds - UPSD is a Actively Managed fund actively managed by Aptus, while TMED is a Health & Biotech Equities fund actively managed by T. Rowe Price. Both are actively managed. Over the past year, UPSD returned 14.81% vs 42.30% for TMED. Their 0.52 correlation means they have sometimes moved together and sometimes differently. UPSD charges 0.79%/yr vs 0.44%/yr for TMED.

Performance

UPSD vs. TMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aptus Large Cap Upside ETF (UPSD) and T. Rowe Price Health Care ETF (TMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UPSD achieves a 7.32% return, which is significantly lower than TMED's 16.91% return.

UPSD

• 1D: -1.51%
• 1M: 2.03%
• 6M: 4.32%
• YTD: 7.32%
• 1Y: 14.81%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 8.90%

TMED

• 1D: -0.74%
• 1M: 1.35%
• 6M: 16.95%
• YTD: 16.91%
• 1Y: 42.30%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 34.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
TMED T. Rowe Price Health Care ETF	$576.43K	$346.09K	$158.73K
UPSD Aptus Large Cap Upside ETF	$285.86K	$253.51K	$392.48K

UPSD vs. TMED - Yearly Performance Comparison

	2026 (YTD)	2025
UPSD Aptus Large Cap Upside ETF	7.32%	12.84%
TMED T. Rowe Price Health Care ETF	16.91%	19.49%

Correlation

The correlation between UPSD and TMED is 0.52, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.52
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025	0.52

The correlation between UPSD and TMED has been stable across timeframes, ranging from 0.52 to 0.52 - a consistent structural relationship.

Return for Risk

UPSD vs. TMED — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

UPSD

UPSD Risk / Return Rank: 42
UPSD Sharpe Ratio Rank: 44
UPSD Sortino Ratio Rank: 41
UPSD Omega Ratio Rank: 42
UPSD Calmar Ratio Rank: 37
UPSD Martin Ratio Rank: 46

TMED

TMED Risk / Return Rank: 91
TMED Sharpe Ratio Rank: 92
TMED Sortino Ratio Rank: 92
TMED Omega Ratio Rank: 90
TMED Calmar Ratio Rank: 90
TMED Martin Ratio Rank: 89

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

UPSD vs. TMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aptus Large Cap Upside ETF (UPSD) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UPSD	TMED	Difference
Sharpe ratio: Return per unit of total volatility	1.03	2.32	-1.29
Sortino ratio: Return per unit of downside risk	1.45	3.34	-1.89
Omega ratio: Gain probability vs. loss probability	1.19	1.40	-0.21
Calmar ratio: Return relative to maximum drawdown	1.25	3.83	-2.58
Martin ratio: Return relative to average drawdown	4.91	13.07	-8.16

UPSD vs. TMED - Sharpe Ratio Comparison

The current UPSD Sharpe Ratio is 1.03, which is lower than the TMED Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of UPSD and TMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UPSD vs. TMED - Drawdown Comparison

The maximum UPSD drawdown since its inception was -23.85%, which is greater than TMED's maximum drawdown of -11.11%. Use the drawdown chart below to compare losses from any high point for UPSD and TMED.

Drawdown Indicators

	UPSD	TMED	Difference
Max Drawdown Largest peak-to-trough decline	-23.85%	-11.11%	-12.74%
Max Drawdown (1Y) Largest decline over 1 year	-11.91%	-11.11%	-0.80%
Current Drawdown Current decline from peak	-1.51%	-1.80%	+0.29%
Average Drawdown Average peak-to-trough decline	-3.70%	-2.41%	-1.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.03%	3.25%	-0.22%

Volatility

UPSD vs. TMED - Volatility Comparison

The current volatility for Aptus Large Cap Upside ETF (UPSD) is 3.11%, while T. Rowe Price Health Care ETF (TMED) has a volatility of 4.97%. This indicates that UPSD experiences smaller price fluctuations and is considered to be less risky than TMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UPSD	TMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.11%	4.97%	-1.86%
Volatility (6M) Calculated over the trailing 6-month period	10.70%	14.01%	-3.31%
Volatility (1Y) Calculated over the trailing 1-year period	14.45%	18.35%	-3.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.59%	18.11%	+2.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.59%	18.11%	+2.48%

UPSD vs. TMED - Expense Ratio Comparison

UPSD has a 0.79% expense ratio, which is higher than TMED's 0.44% expense ratio.

Dividends

UPSD vs. TMED - Dividend Comparison

UPSD's dividend yield for the trailing twelve months is around 0.67%, more than TMED's 0.47% yield.

Position	TTM	2025	2024
TMED T. Rowe Price Health Care ETF	0.47%	0.54%	0.00%
UPSD Aptus Large Cap Upside ETF	0.67%	0.67%	0.06%

Frequently Asked Questions

Can I hold both UPSD and TMED in my portfolio?

UPSD and TMED have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UPSD or TMED?

TMED has higher volatility (4.97%) compared to UPSD (3.11%). In terms of maximum drawdown, UPSD dropped -23.85% vs TMED's -11.11%.

Which ETF is better, UPSD or TMED?

On 1-year performance, TMED leads with 42.30% vs 14.81% for UPSD. On fees, TMED is cheaper at 0.44% per year. On volatility, UPSD has been the lower-risk option at 3.11%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, UPSD or TMED?

Over the 1-year period, TMED has performed better with a 42.30% return vs 14.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, UPSD or TMED?

TMED is cheaper with a 0.44% expense ratio, compared with 0.79% for UPSD.

Which ETF pays a higher dividend yield, UPSD or TMED?

UPSD has the higher dividend yield at 0.67%, compared with 0.47% for TMED.

What is the main difference between UPSD and TMED?

UPSD is categorized as Actively Managed, while TMED is Health & Biotech Equities. They also come from different issuers: Aptus and T. Rowe Price. Their fees differ too: 0.79% for UPSD and 0.44% for TMED.

Which has better risk-adjusted returns?

TMED currently has the higher Sharpe Ratio (2.32 vs 1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.